| Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell … E Mössner, P Brünker, S Moser, U Püntener, C Schmidt, S Herter, R Grau, ... Blood, The Journal of the American Society of Hematology 115 (22), 4393-4402, 2010 | 1113 | 2010 |
| BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas J Kluiver, S Poppema, D de Jong, T Blokzijl, G Harms, S Jacobs, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 961 | 2005 |
| Distribution of T cell subsets in human lymph nodes. S Poppema, AK Bhan, EL Reinherz, RT McCluskey, SF Schlossman The Journal of experimental medicine 153 (1), 30-41, 1981 | 487 | 1981 |
| Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hidgkin's disease: report from the European Task … V Diehl, M Sextro, J Franklin, ML Hansmann, N Harris, ES Jaffe, ... J Clin Oncol 17, 776-783, 1999 | 477 | 1999 |
| Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer K Kok, J Osinga, B Carritt, MB Davis, AH van der Hout, AY van der Veen, ... Nature 330 (6148), 578-581, 1987 | 476 | 1987 |
| High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma A Van den Berg, L Visser, S Poppema The American journal of pathology 154 (6), 1685-1691, 1999 | 459 | 1999 |
| European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin … I Anagnostopoulos, ML Hansmann, K Franssila, M Harris, NL Harris, ... Blood, The Journal of the American Society of Hematology 96 (5), 1889-1899, 2000 | 418 | 2000 |
| Location of T cell and major histocompatibility complex antigens in the human thymus. AK Bhan, EL Reinherz, S Poppema, RT McCluskey, SF Schlossman The Journal of experimental medicine 152 (4), 771-782, 1980 | 354 | 1980 |
| High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma A Van den Berg, BJ Kroesen, K Kooistra, D de Jong, J Briggs, T Blokzijl, ... Genes, Chromosomes and Cancer 37 (1), 20-28, 2003 | 347 | 2003 |
| Primary breast lymphoma: an immunohistologic study of 20 new cases JC Hugh, FI Jackson, J Hanson, S Poppema Cancer 66 (12), 2602-2611, 1990 | 315 | 1990 |
| Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma J Kluiver, E Haralambieva, D de Jong, T Blokzijl, S Jacobs, BJ Kroesen, ... Genes, Chromosomes and Cancer 45 (2), 147-153, 2006 | 310 | 2006 |
| Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. W Timens, A Boes, T Rozeboom-Uiterwijk, S Poppema Journal of immunology (Baltimore, Md.: 1950) 143 (10), 3200-3206, 1989 | 305 | 1989 |
| Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. S Poppema, H Hollema, L Visser, H Vos The American journal of pathology 127 (3), 418, 1987 | 294 | 1987 |
| Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis … HF Eggink, HJ Houthoff, S Huitema, CH Gips, S Poppema Clinical and experimental immunology 50 (1), 17, 1982 | 243 | 1982 |
| Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia BA Robbins, DJ Ellison, JC Spinosa, CA Carey, RJ Lukes, S Poppema, ... Blood 82 (4), 1277-1287, 1993 | 236 | 1993 |
| HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma M Niens, RF Jarrett, B Hepkema, IM Nolte, A Diepstra, M Platteel, ... Blood, The Journal of the American Society of Hematology 110 (9), 3310-3315, 2007 | 212 | 2007 |
| Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma A Diepstra, M Niens, E Vellenga, GW Van Imhoff, IM Nolte, M Schaapveld, ... The Lancet 365 (9478), 2216-2224, 2005 | 208 | 2005 |
| Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t (14; 18), 3q27, or other translocations: t (14; 18) and 3q27 are mutually exclusive AG Bosga-Bouwer, GW van Imhoff, R Boonstra, A van der Veen, ... Blood, The Journal of the American Society of Hematology 101 (3), 1149-1154, 2003 | 204 | 2003 |
| Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile JH Gibcus, LP Tan, G Harms, RN Schakel, D de Jong, T Blokzijl, P Möller, ... Neoplasia 11 (2), 167-IN9, 2009 | 202 | 2009 |
| Prevention and reversal of renal allograft rejection by antibody against CD45RB AI Lazarovits, S Poppema, Z Zhang, M Khandaker, CE Le Feuvre, ... Nature 380 (6576), 717-720, 1996 | 201 | 1996 |
Anke van den BergProfessor of Molecular biology of malignant B cell lymphomas, University of Groningen, UniversityVerificeret mail på umcg.nl
